Indigo therapeutics

Indigo therapeutics Indigo designs, manufactures and supplies innovative dietary supplements focused on gastrointestinal tract (GIT) pathologies and related deficiencies

The whole Indigo team sends you its best wishes
29/12/2017

The whole Indigo team sends you its best wishes

Pharmabiotics 2017: Indigo goes out
21/03/2017

Pharmabiotics 2017: Indigo goes out

17/11/2016

In early 2017, Indigo will initiate marketing for its first products and set up several clinical trials

17/11/2016

Indigo has signed 2 R&D programs on probiotics with INRA (Institut National de la Recherche Agronomique) and UMR PAM/AgroSup

08/10/2015

Indigo addresses medical problems or conditions which currently lack of efficient or well-tolerated solutions. Besides, Indigo provides a clear rational while exploiting the potential of probiotics / synbiotics still faces some uncertainty among healthcare professionals.

Besides opportunistic developments, our R&D aims at producing new generation probiotics / synbiotics combining a selection of relevant strains in relation to the progresses on microbiota, a microencapsulation technology promoting the survival and the production of molecules of interest, and a pharmaceutical macro-encapsulation vectorizing active ingredients to the therapeutic target.

Adresse

5, Rue Salneuve
Paris
75017

Site Web

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Indigo therapeutics publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Raccourcis

Partager

Type